DG
32
-2
CA
40
4
CTAS
64
2
FCX
47
-9
PBI
30
7
OI
26
-2
EMC
77
-8
ILMN
36
10
WEC
45
9
HAL
41
11
VMC
57
3
ICE
67
3
SLG
71
-4
PM
52
-4
BAX
41
3
CL
77
2
AVY
74
2
NWL
32
4
DAL
48
-2
SWKS
57
-8
DG
32
-2
CA
40
4
CTAS
64
2
FCX
47
-9
PBI
30
7
OI
26
-2
EMC
77
-8
ILMN
36
10
WEC
45
9
HAL
41
11
VMC
57
3
ICE
67
3
SLG
71
-4
PM
52
-4
BAX
41
3
CL
77
2
AVY
74
2
NWL
32
4
DAL
48
-2
SWKS
57
-8
Financhill
Back

Paramount Global Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Sell
16

PARA
Paramount Global

Last Price:
10.15
Seasonality Move:
0.09%
Sell
43

RARE
Ultragenyx Pharmaceutical

Last Price:
39.58
Seasonality Move:
3.65%
Sell
16
Paramount Global (PARA) is a Sell

Is Paramount Global a Buy, Sell or Hold?

  • The current Paramount Global [PARA] share price is $10.12. The Score for PARA is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
  • PARA is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
43
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $39.60. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PARA Stock Price Chart

What is Paramount Global's stock price today?

  • The Paramount Global share price today is $10.12
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PARA is experiencing slight selling pressure.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $39.60
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing buying pressure, which is a positive indicator for future bullish movement.

PARA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.6 Sell
Relative Strength Index (14 RSI): 35.67 Sell
Chaikin Money Flow: -2068832 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (10.59 - 12.41) Sell
Bollinger Bands (100): (10.86 - 12.98) Sell

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.73 Sell
Relative Strength Index (14 RSI): 45.77 Sell
Chaikin Money Flow: 722527 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.99 - 42.29) Sell
Bollinger Bands (100): (41.03 - 48.83) Sell

PARA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 10.29 Sell
20-day SMA: 11.33 Sell
50-day SMA: 11.86 Sell
200-day SMA: 12.68 Sell
8-day EMA: 10.37 Sell
20-day EMA: 11.08 Sell
50-day EMA: 11.64 Sell
200-day EMA: 13.17 Sell

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 40.38 Sell
20-day SMA: 40.41 Sell
50-day SMA: 41.94 Sell
200-day SMA: 42.46 Sell
8-day EMA: 39.76 Sell
20-day EMA: 40.54 Sell
50-day EMA: 42.03 Sell
200-day EMA: 43.46 Sell

Paramount Global Earnings Growth & PARA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.04 per share, an increase this year of $0.76 per share, and an increase next year of $0.13 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.

Paramount Global Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):